FDA approves venetoclax for chronic lymphocytic leukaemia The US Food and Drug Administration has approved venetoclax for the treatment of chronic lymphocytic leukaemia.…
Migalastat set for approval as first oral therapy for Fabry disease The European Medicines Agency has recommended the approval of migalastat for the treatment of the rare genetic disorder Fabry disease.…
Gene therapy for ‘bubble boy’ syndrome on track for EU approval Children with an extremely rare immune deficiency disease are set to have access to gene therapy, following a recommendation for approval by the European Medicines Agency.…
Curcumin boosts immune cell power against tuberculosis Incubating cells with turmeric compound reduced Mycobacterium tuberculosis infection.…
Sperm activation finding could lead to new contraceptives Enzyme that activates sperm mobility could lead to new contraceptives or treatment for male infertility.…
FDA approves coagulation factor-albumin fusion protein to treat haemophilia B Idelvion, a coagulation factor-albumin fusion protein product for use in children and adults with haemophilia B, has been approved by the US Food and Drug Administration.…
Study identifies how immune cells attack malignant tumours New research shows how the genetic diversity of malignant tumours is identified by the body’s immune system, opening the door to the development of improved anticancer therapies.…
Study shows how stress increases breast cancer metastasis Researchers suggest aggressive breast cancer could be slowed by targeting a specific signalling loop.…
Delve into the complex and interesting world of the immune system ‘Immunity’, by William E Paul. Pp xiii+260 £19.50. Baltimore: John Hopkins University Press; 2016. 978 1 421 41801 8…
‘Neurostatin’ prevents Alzheimer’s-related amyloid formation Roundworm study shows bexarotene could inhibit early step of amyloid-beta aggregation.…